BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18922909)

  • 21. Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.
    Gold DV; Modrak DE; Schutsky K; Cardillo TM
    Int J Cancer; 2004 Apr; 109(4):618-26. PubMed ID: 14991585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
    Bruns CJ; Shrader M; Harbison MT; Portera C; Solorzano CC; Jauch KW; Hicklin DJ; Radinsky R; Ellis LM
    Int J Cancer; 2002 Nov; 102(2):101-8. PubMed ID: 12385004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine.
    Lee ES; Lee JY; Kim H; Choi Y; Park J; Han JK; Choi BI
    Ultrasound Med Biol; 2013 Nov; 39(11):1991-2000. PubMed ID: 23972483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model.
    Bevis KS; McNally LR; Sellers JC; Della Manna D; Londoño Joshi A; Amm H; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2011 Apr; 121(1):193-9. PubMed ID: 21211830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [
    Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM
    Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.
    Bornmann C; Graeser R; Esser N; Ziroli V; Jantscheff P; Keck T; Unger C; Hopt UT; Adam U; Schaechtele C; Massing U; von Dobschuetz E
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):395-405. PubMed ID: 17554540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
    Bruns CJ; Harbison MT; Davis DW; Portera CA; Tsan R; McConkey DJ; Evans DB; Abbruzzese JL; Hicklin DJ; Radinsky R
    Clin Cancer Res; 2000 May; 6(5):1936-48. PubMed ID: 10815919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes.
    Yada A; Yazawa M; Ishida S; Yoshida H; Ichikawa K; Kurakata S; Fujiwara K
    Ann Oncol; 2008 Jun; 19(6):1060-7. PubMed ID: 18304965
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Yang H; Tong Z; Shen L; Sun YU; Hoffman RM; Huang J
    Anticancer Res; 2020 Sep; 40(9):4969-4978. PubMed ID: 32878785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft.
    Kotopoulis S; Delalande A; Popa M; Mamaeva V; Dimcevski G; Gilja OH; Postema M; Gjertsen BT; McCormack E
    Mol Imaging Biol; 2014 Feb; 16(1):53-62. PubMed ID: 23877869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer.
    Nesbitt H; Sheng Y; Kamila S; Logan K; Thomas K; Callan B; Taylor MA; Love M; O'Rourke D; Kelly P; Beguin E; Stride E; McHale AP; Callan JF
    J Control Release; 2018 Jun; 279():8-16. PubMed ID: 29653222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel CDC25B Promoter-Based Oncolytic Adenovirus Inhibited Growth of Orthotopic Human Pancreatic Tumors in Different Preclinical Models.
    Weber HL; Gidekel M; Werbajh S; Salvatierra E; Rotondaro C; Sganga L; Haab GA; Curiel DT; Cafferata EG; Podhajcer OL
    Clin Cancer Res; 2015 Apr; 21(7):1665-74. PubMed ID: 25573380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.
    Jia L; Zhang MH; Yuan SZ; Huang WG
    World J Gastroenterol; 2005 Jan; 11(3):447-50. PubMed ID: 15637766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM
    Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.
    Kimura K; Sawada T; Komatsu M; Inoue M; Muguruma K; Nishihara T; Yamashita Y; Yamada N; Ohira M; Hirakawa K
    Clin Cancer Res; 2006 Aug; 12(16):4925-32. PubMed ID: 16914581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.
    Kim H; Buchsbaum DJ; Zinn KR
    Mol Imaging Biol; 2016 Jun; 18(3):325-33. PubMed ID: 26552657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer.
    Kramer RM; Russell J; Humm JL
    Cancer Biother Radiopharm; 2015 Sep; 30(7):299-304. PubMed ID: 26203552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
    Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.
    Matsumoto T; Komori T; Yoshino Y; Ioroi T; Kitahashi T; Kitahara H; Ono K; Higuchi T; Sakabe M; Kori H; Kano M; Hori R; Kato Y; Hagiwara S
    Pharm Res; 2021 Jun; 38(6):1093-1106. PubMed ID: 33961188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of gemcitabine on radiosensitization, apoptosis, and Bcl-2 and Bax protein expression in human pancreatic cancer xenografts in nude mice.
    Shen ZT; Wu XH; Wang L; Li B; Zhu XX
    Genet Mol Res; 2015 Dec; 14(4):15587-96. PubMed ID: 26634526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.